HOME >> MEDICINE >> NEWS
Breakthrough in hormonal breast cancer therapy

Highlights from the ground-breaking study into the management of early breast cancer the ATAC 'Arimidex', Tamoxifen Alone or in Combination) study were presented today at the 18th UICC Cancer Congress in Oslo.

These data mark a breakthrough in hormonal breast cancer therapy as they clearly demonstrate that anastrozole is significantly more effective than the current 'gold standard' treatment tamoxifen in terms of

  • improving disease-free survival for postmenopausal women with early breast cancer
  • reducing the risk of endometrial cancer
  • reducing incidence of hot flushes and thromboembolic events

The ATAC results show that anastrozole, an aromatase inhibitor (AI), is more effective in reducing the risk of cancer recurring in the same breast, the opposite breast, or elsewhere in the body when compared to tamoxifen. This is the first time an AI has been proved to be superior to tamoxifen in early breast cancer.

Anastrozole was also associated with a number of important tolerability advantages over tamoxifen a key consideration in early breast cancer where women who are otherwise 'healthy' routinely take hormonal treatment for up to 5 years after initial tumour-removing surgery. Perhaps the most important of these, as presented in Oslo today, is the benefit of anastrozole in reducing the risk of developing abnormalities of the lining of the womb (endometrium) when compared to tamoxifen. Data presented from a sub-study of 279 trial patients*) demonstrated that anastrozole halved the risk of endometrial abnormalities compared to tamoxifen.

Speaking today at the UICC Congress, Dr Sean Duffy, from the Division of Obstetrics and Gynaecology at St James University Hospital in Leeds, UK, and lead ATAC sub-protocol investigator said; "This is an extremely important finding. Even though the risk of developing endometrial cancer when taking tamoxifen is small, and the bene
'"/>

Contact: Hanna Hanes
hhaanes@online.no
47-90-15-60-40
Norwegian Cancer Society
5-Jul-2002


Page: 1 2

Related medicine news :

1. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
2. Breakthrough therapies treat Crohns disease
3. Breakthrough cancer treatment Avastin receives first approval in the US
4. Breakthroughs in research may bring hope to 1.5 million Americans suffering from peanut allergy
5. Breakthrough! UNC scientists research promises improved X-ray machines using carbon nanotubes
6. Breakthrough pain in cancer associated with need for increased medical services, higher medical costs
7. Simple test predicts ability to grow new blood vessels: Breakthrough in battle against heart disease, diabetes, cancer
8. Breakthrough New Therapy Uses Antibody-Targeted Chemotherapy To Fight Leukemia
9. Low-Tech Treatment Proves A Life-Saver In Research Breakthrough
10. Breakthrough? Study Finds Dopamine Cannot Be Source Of Pleasure In Brain
11. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 /PRNewswire/ ... health and big data solutions, today announced that its MyDario product is ... your local TV listings for when The Dr. Oz Show airs in ... The nine-time ... month. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology:
Cached News: